InvestorsHub Logo
Followers 2
Posts 133
Boards Moderated 0
Alias Born 03/13/2013

Re: MolBiol post# 9255

Wednesday, 04/23/2014 11:57:40 AM

Wednesday, April 23, 2014 11:57:40 AM

Post# of 696710
I got the distinct feeling in the conversation with the ASCO representative that they were trying to crack down on the practice of presenting data when designated as a TPS abstract. The woman that I spoke with said they had strongly encouraged their reviewers to not even allow the mention that "data will be presented" in the published abstract. However, it obviously has slipped through in the past. And also, with such a large footprint at the conference NWBO might feel a little like flicking their nose up to the rules. Overall, I'm very pessimistic that we will have any indication on the 14th that their will be data in the poster unless they get an exception, which doesn't appear to have happened (no caret in number). I'm still hopeful that NWBO will at least put some data in the poster regardless of the policy. The abstract should at least give us a good idea what the bulk of the poster will pertain too. Be it mouse data, trial design or something else.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News